T cell costimulation via OX40 is known increase CD4 + T cell expansion and effector function and enhances the development of T cell memory. OX40 costimulation can also prevent, and even reverse, CD4 + T cell anergy. However, the role of OX40 in CD8 + T cell function is less well defined, particularly in the setting of immune tolerance. To determine the effects of OX40 costimulation on the induction of the host CO8 + T cell repertoire to an endogenous tumor Ag, we examined the fate of CD8 + T cells specific for the immunodominant rat HER-2/neu epitope, RNEU 420-429 , in FVB MMTV-neu (neu-N) mice, which express rat HER-2/neu protein in a predominantly mammary-restricted fashion. We show that the RNEU 420-429 -specific T cell repertoire in neu-N mice expands transiently after vaccination with a neu-targeted GM-CSF-secreting whole-cell vaccine, but quickly declines to an undetectable level. However, OX40 costimulation, when combined with GM-CSF-secreting tumor-targeted vaccination, can break established CD8 + T cell tolerance in vivo by enhancing the expansion, and prolonging the survival and effector function of CO8 + T cells specific for RNEU 420-429 . Moreover, we demonstrate thai OX40 expression is up-regulated on both CD4 + and CD8 + T cells shortly after administration of a GM-CSF expressing vaccine. These studies highlight the increased efficacy of OX40 costimulation when combined with a GM-CSF-secreting vaccine, and define a new role for OX40 costimulation of CD8 + T cells in overcoming tolerance and boosting antitumor immunity. Copyright © 2006 by The American Association of Immunologists, Inc.
Murata, S., Ladle, B. H., Kim, P. S., Lutz, E. R., Wolpoe, M. E., Ivie, S. E., … Reilly, R. T. (2006). OX40 Costimulation Synergizes with GM-CSF Whole-Cell Vaccination to Overcome Established CD8 + T Cell Tolerance to an Endogenous Tumor Antigen . The Journal of Immunology, 176(2), 974–983. https://doi.org/10.4049/jimmunol.176.2.974